Seehra Jasbir (CIK 1732369) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-06). Recent activity: Buy KROS (55,000 shares), Sell KROS (7,015 shares), Buy KROS (90,500 shares), Buy KROS (49,367 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-06 | Keros Therapeutics, Inc. (KROS) | CHIEF EXECUTIVE OFFICER | Buy | 55,000 | $16,500 |
| 2026-02-20 | Keros Therapeutics, Inc. (KROS) | CHIEF EXECUTIVE OFFICER | Sell | 7,015 | $113,433 |
| 2025-09-05 | Keros Therapeutics, Inc. (KROS) | CHIEF EXECUTIVE OFFICER | Buy | 90,500 | $0 |
| 2025-04-07 | Keros Therapeutics, Inc. (KROS) | CHIEF EXECUTIVE OFFICER | Buy | 49,367 | $14,810 |
Source: SEC Form 4 filings · as of 2026-04-06